Home » Topics » BioWorld Science

BioWorld Science
RSS

Sulanda approved in China for non-pancreatic NETs

Dec. 31, 2020

Phase II results reported for AXL inhibitor bemcentinib in patients failing hypomethylating agents

Dec. 31, 2020

Activity against AML seen in vitro and in vivo with LSD1 inhibitor CPI-482

Dec. 31, 2020

Polish authorities grant new indication for Dexaven to treat COVID-19

Dec. 30, 2020

Opdivo SCLC indication withdrawn in U.S.

Dec. 30, 2020

Final results from phase III BRIDGE study of pegunigalsidase alfa for Fabry disease

Dec. 30, 2020

COVID anniversary coincides with more transmissible strains

Dec. 30, 2020

New clinical program studies Emergent's COVID-HIG product candidate for COVID-19 prophylaxis

Dec. 30, 2020

U.K. MHRA authorizes AstraZeneca's COVID-19 vaccine for emergency supply

Dec. 30, 2020

NUSAP1 linked to poor prognosis in chronic lymphocytic leukemia

Dec. 30, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...